BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.351
+0.009 (2.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $6.31 million as of February 21, 2025. Its market cap has decreased by -17.87% in one year.
Market Cap
6.31M
Enterprise Value
2.42M
1-Year Change
-17.87%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $6.31M, a decrease of -85.01%. That is a compound annual growth rate of -34.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 6.31M | 25.60% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 218.08B |
| BHP Group | 133.43B |
| Rio Tinto Group | 109.69B |
| The Sherwin-Williams Company | 86.48B |
| Ecolab | 74.95B |
| Southern Copper | 73.97B |
| Air Products and Chemicals | 68.94B |
| CRH plc | 67.86B |